Optic Nerve Damage Associated With GLP-1 Drugs: Troubling Evidence GLP-1 receptor agonists such as Wegovy/Ozempic (semaglutide), Zepbound (tirzepatide) and Saxenda (liraglutide) have been instrumental in addressing diabetes and obesity, yet recent peer-reviewed research reveals troubling evidence linking these drugs to NAION, a condition characterized by reduced blood flow causing sudden vision loss due to optic nerve damage
Comparatively, traditional diabetes treatments, which may include a mix of generics or well-known brands, are often more budget-friendly in terms of immediate out-of-pocket costs
The womans doctor had prescribed her a GLP-1 drug for weight loss, even though the woman, who had suffered from an eating disorder for 28 years, had abused numerous medications to lose weight
Getting Better Results with Combination Therapies Studies comparing microneedling alone versus microneedling combined with PRP, growth factor serums, or other biologics consistently show incremental improvement with combination approaches
These structural comparisons therefore suggested that the crystal structure of Cp1B adopts a closed active site, possibly as a result of MES binding in the active site
Highly targeted application design, perfect for treating localized dark spots and melasma on the face and neck
